Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Asthma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00689806
What this trial is testing

Evaluation of Lovastatin in Severe Persistent Asthma

Who this might be right for
Severe Persistent Asthma
University of Chicago
Not applicableUnknownNCT05787678
What this trial is testing

Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion

Who this might be right for
Asthma; Eosinophilic
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Post-approval studies (Phase 4)Looking for participantsNCT07241117
What this trial is testing

CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

Who this might be right for
Moderate to Severe Asthma
Washington University School of Medicine 2,000
Not applicableStudy completedNCT04680611
What this trial is testing

Severe Asthma, MepolizumaB and Affect: SAMBA Study

Who this might be right for
Severe Eosinophilic AsthmaPsychological DistressAnxiety+14 more
University Hospital Southampton NHS Foundation Trust 120
Post-approval studies (Phase 4)Looking for participantsNCT04763447
What this trial is testing

Short Treatment with Omalizumab for Severe Asthma

Who this might be right for
Asthma
Assistance Publique - Hôpitaux de Paris 234
Testing effectiveness (Phase 2)WithdrawnNCT00675649
What this trial is testing

A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma

Who this might be right for
Asthma
Centocor, Inc.
Testing effectiveness (Phase 2)Study completedNCT03683576
What this trial is testing

GB001 in Adult Subjects With Moderate to Severe Asthma

Who this might be right for
Asthma
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. 481
Not applicableStudy completedNCT02990247
What this trial is testing

Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study

Who this might be right for
Asthma
University Hospital, Bordeaux 120
Testing effectiveness (Phase 2)Study completedNCT01000506
What this trial is testing

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

Who this might be right for
Asthma
GlaxoSmithKline 621
Not applicableLooking for participantsNCT05691218
What this trial is testing

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department

Who this might be right for
Moderate Asthma ExacerbationSevere Asthma Exacerbation
Poitiers University Hospital 60
Not applicableActive Not RecruitingNCT05733143
What this trial is testing

Using Exercise-testing to Explore Patient Differences in Severe Asthma

Who this might be right for
Asthma
Queen's University, Belfast 64
Not applicableStudy completedNCT00090740
What this trial is testing

Genetic Risk Factors for Severe Asthma

Who this might be right for
Asthma
National Institute of Allergy and Infectious Diseases (NIAID) 600
Not applicableStudy completedNCT06922760
What this trial is testing

Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts

Who this might be right for
Asthma
University of Michigan 233
Not applicableStudy completedNCT04808518
What this trial is testing

Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

Who this might be right for
Asthma
AstraZeneca 74
Post-approval studies (Phase 4)Study completedNCT01705964
What this trial is testing

Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation

Who this might be right for
Asthma
University of Louisville 49
Very early researchStudy completedNCT02740049
What this trial is testing

In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma

Who this might be right for
Asthma
Imperial College London 9
Testing effectiveness (Phase 2)UnknownNCT02153541
What this trial is testing

Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults

Who this might be right for
Asthma
Global United Pharmaceutical Corporation 50
Not applicableEnded earlyNCT04340583
What this trial is testing

Subjective Sleep Quality and Sleep Disorders in Patients With Severe Asthma

Who this might be right for
Asthma
Istituti Clinici Scientifici Maugeri SpA 16
Testing effectiveness (Phase 2)UnknownNCT06642961
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma

Who this might be right for
Asthma
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50
Next Page